Therefore, the Zacks rating upgrade for Inspire basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price. The change in ...

Inspire Medical Systems released preliminary results indicated second-quarter and full-year revenue above analysts' estimates. The sleep apnea device maker expects second quarter sales to be 30% ...

Inspire Medical Systems ... This raises our optimism about the stock. Per the preliminary report, full-year 2024 total revenues are estimated to be between $802.6 million and $802.8 million ...

BofA upgrades Inspire Medical to Buy, setting a $255 price target. The company aims for $950 million in 2025 revenue, with a focus on new product launches and expansion. Shopify Posts Upbeat ...